Farmers & Merchants Trust Company’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,393
Closed -$404K 200
2024
Q3
$404K Sell
3,393
-54
-2% -$7.2K 0.1% 135
2024
Q2
$492K Buy
3,447
+201
+6% +$26.6K 0.13% 115
2024
Q1
$417K Buy
3,246
+212
+7% +$25.2K 0.1% 126
2023
Q4
$314K Buy
3,034
+6
+0.2% +$593 0.08% 138
2023
Q3
$275K Buy
3,028
+110
+4% +$9.69K 0.08% 132
2023
Q2
$236K Buy
+2,918
New +$238K 0.06% 158

Other funds holding NVO

Farmers & Merchants Trust Company's NVO Position: Q4 2024 in Review

Farmers & Merchants Trust Company sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 3,393 shares — an estimated $404K sold.

Farmers & Merchants Trust Company first reported a position in NVO in Q2 2023 and held it in 6 quarters. The position peaked at $492K in Q2 2024. 1,664 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Farmers & Merchants Trust Company reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Farmers & Merchants Trust Company sold 3,393 Novo Nordisk shares in Q4 2024, an estimated $404K.
  • Farmers & Merchants Trust Company first reported a position in Novo Nordisk in Q2 2023 and held it in 6 quarters.
  • Farmers & Merchants Trust Company's Novo Nordisk position peaked at $492K in Q2 2024.
  • 1,664 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Farmers & Merchants Trust Company's 13F filing for Q4 2024, filed 15 Jan 2025.